A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study.

NCT ID: NCT06039410

Last Updated: 2024-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-15

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test a novel medical device (ISO-101) in patients diagnosied with orthostatic hypotension. The main question\[s\] it aims to answer are:

* to determine whether the ISO-101 device demonstrates a signal of efficacy in people with OH and whether it is worthy of further clinical evaluation.
* Assess the safety and performance of the ISO-101 device in patients with orthostatic hypotension.

Participants will use the device under controlled conditions and have the following parameters measured before and after standing up:

* blood pressure
* markers of peripheal vascular resistence
* sympathetic nervous system activity measure before and after standing up

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a proof of principle study aimed at evaluating if there is a signal of efficacy from use of the ISO-101 device in people with orthostatic hypotension. The study is a single centre, unblinded, pre-post study. All participants will act as their own control, and all will receive the intervention.The primary objective is to determine whether the ISO-101 device demonstrates a signal of efficacy in people with OH and whether it is worthy of further clinical evaluation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthostatic Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Thus, the study is a single centre, unblinded, pre-post study. All participants will act as their own control, and all will receive the intervention.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment

ISO-101 Device

Group Type EXPERIMENTAL

ISO-101

Intervention Type DEVICE

ISO-101 is an experimental wearable class 1 medical device which when used is able to raise the blood pressure upon standing via controlled isometric muscular contractions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ISO-101

ISO-101 is an experimental wearable class 1 medical device which when used is able to raise the blood pressure upon standing via controlled isometric muscular contractions

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willing and able to give informed consent for participation in the study
* Adults aged over 18 years with a clinical diagnosis of orthostatic hypotension
* A drop in systolic BP of ≥20 mmHg (with or without a drop in diastolic BP ≥10 mmHg) within 3 minutes of standing up from a supine position
* Able to stand up from a supine position (with assistance if required)

Exclusion Criteria

* Cognitively unable to follow research procedures
* Physically unable to use the ISO-101 device (e.g., unilateral arm weakness due to stroke)
* Acute or reversible cause of OH (e.g., haemorrhage or sepsis)
* Current pregnancy
* Participants on insulin (participants will be asked to refrain from breakfast on the morning of their assessment)
* Resting supine systolic BP ≥180 or diastolic ≥110 mmHg
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

Sponsor Role collaborator

Isotech Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Falls and Syncope Service, Older People's Medicine, The Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle upon Tyne, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Neil Fawkes, MBChB DPM FFPM

Role: CONTACT

+44 (0) 2830 835 500

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr Frith, MBChB FRCP PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISO0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autonomic Determinants of POTS - Pilot1
NCT04050410 ACTIVE_NOT_RECRUITING EARLY_PHASE1
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ACTIVE_NOT_RECRUITING EARLY_PHASE1
Effect of Exercise in OI
NCT00770484 COMPLETED NA
Pathophysiology of Orthostatic Intolerance
NCT00608725 ACTIVE_NOT_RECRUITING NA